Claritin-d Tablet, Extended Release
Product Images NDC 11523-0102

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Claritin-d (NDC 11523-0102). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bayer Healthcare Llc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton Label Back (Claritin D 24hr 10ct Carton1)

Drug Facts text panel for Claritin-D 24 Hour (loratadine pseudoephedrine sulfate) extended-release tablets. The panel includes active ingredients and their amounts, uses, warnings, directions, other information such as storage instructions, inactive ingredients, and contact information for questions or comments. The text is printed in blue and black on a white background within a blue border.*

FDA Label Image

Carton Label Front (Claritin D 24hr 10ct Carton2)

Packaging label for Claritin-D 24 Hour extended release tablets, containing pseudoephedrine sulfate 240 mg and loratadine 10 mg. The box indicates 10 extended release tablets for oral use, providing 10 days of relief. Labeler is Bayer HealthCare LLC. The design features a blue background with white and yellow text, a cloud image, and a green grass field at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.